Simultaneous expression analysis of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic primary hyperparathyroidism in Asian Indians
Authors:
- Sanjay Kumar BhadadaSBSanjay Kumar Bhadada
- Uma Nahar SaikiaUSUma Nahar Saikia
- Naresh SachdevaNSNaresh Sachdeva
- Arunanshu BeheraABArunanshu Behera
- Ashutosh Kumar AryaAAAshutosh Kumar Arya
- Sadhna SharmaSSSadhna Sharma
- Anil BhansaliABAnil Bhansali
- Ambrish MithalAMAmbrish Mithal
- Sudhaker D RaoSRSudhaker D Rao
- 1 July 2013
- journal article
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 169 (1) , 109-116
Abstract
Background: To explore underlying molecular mechanisms in the pathogenesis of symptomatic sporadic primary hyperparathyroidism (PHPT).Materials and methods: Forty-one parathyroid adenomas from patients with symptomatic PHPT and ten normal parathyroid glands either from patients with PHPT (n=3) or from euthyroid patients without PHPT during thyroid surgery (n=7) were analyzed for vitamin D receptor (VDR), calcium-sensing receptor (CASR), cyclin D1 (CD1), and parathyroid hormone (PTH) expressions. The protein expressions were assessed semiquantitatively by immunohistochemistry, based on percentage of positive cells and staining intensity, and confirmed by quantitative real-time PCR.Results: Immunohistochemistry revealed significant reductions in VDR (both nuclear and cytoplasmic) and CASR expressions and significant increases in CD1 and PTH expressions in adenomatous compared with normal parathyroid tissue. Consistent with immunohistochemistry findings, bothVDRandCASRmRNAs were reduced by 0.36- and 0.45-fold change (PCD1andPTHmRNAs were increased by 9.4- and 17.4-fold change respectively (PPTHmRNA correlated with plasma PTH (r=0.864;PCD1mRNA correlated with adenoma weight (r=0.715;PVDRandCASRmRNA levels and serum Ca, plasma intact PTH, or 25-hydroxyvitamin D levels. In addition, there was no relationship between the decreases inVDRandCASRmRNA expressions and the increases inPTHandCD1mRNA expressions.Conclusions: The expression of both VDR and CASR are reduced in symptomatic PHPT in Asian Indians. In addition,CD1expression was greatly increased and correlated with adenoma weight, implying a potential role for CD1 in adenoma growth and differential clinical expression of PHPT.Keywords
This publication has 30 references indexed in Scilit:
- Reduced vitamin D receptor expression in parathyroid adenomas: implications for pathogenesisClinical Endocrinology, 2000
- Reduced Parathyroid Vitamin D Receptor Messenger Ribonucleic Acid Levels in Primary and Secondary HyperparathyroidismThe Journal of Clinical Endocrinology & Metabolism, 2000
- Alternative Genetic Pathways in Parathyroid TumorigenesisThe Journal of Clinical Endocrinology & Metabolism, 1999
- Novel Chromosomal Abnormalities Identified by Comparative Genomic Hybridization in Parathyroid AdenomasThe Journal of Clinical Endocrinology & Metabolism, 1998
- Parathyroid hormone activation of the 25-hydroxyvitamin D 3 -1α-hydroxylase gene promoterProceedings of the National Academy of Sciences, 1998
- Calcium-Ion–Sensing Cell-Surface ReceptorsNew England Journal of Medicine, 1995
- Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3.Proceedings of the National Academy of Sciences, 1992
- Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma.Journal of Clinical Investigation, 1989
- Abnormal calcium-regulated PTH release in normal parathyroid tissue from patients with adenomaThe American Journal of Medicine, 1981
- Control of 25-Hydroxycholecalciferol Metabolism by Parathyroid GlandsProceedings of the National Academy of Sciences, 1972